Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches.
Explore this paper's citation graph
Summary
This report reviews the evolution of treatment of visceral leishmaniasis, considers the interaction of the immune response and chemotherapy, highlights therapeutic successes and failures, examines advantages and disadvantages of current treatments, and looks at future therapeutic approaches to the management of this disseminated intracellular protozoal infection.
- Type
- review
- Published
- 2000-01-01
- Cited by
- 110
- References
- 201
- Access
- Open access
- OpenAlex
- https://openalex.org/W2014662504
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:41805467
Keywords
Miltefosine, Visceral leishmaniasis, Leishmaniasis, Medicine, Paromomycin
References
- Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B.
- Clinicoepidemiological study of drug resistance in Indian kala - azar
- Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years.
- Activity of a Heat-Induced Reformulation of Amphotericin B Deoxycholate (Fungizone) against Leishmania donovani
- Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis.
- Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.
- TREATMENT OF KALA-AZAR WITH AMPHOTERICIN B.
- Efficacy of sodium antimony gluconate and ketoconazole in the treatment of kala-azar--a comparative study.
- Leishmaniasis: Public health aspects and control
- Efficacy and Tolerability of Liposomal Amphotericin B (Ambisome) in the Treatment of Visceral Leishmaniasis in Brazil.
- Epidemiology of visceral leishmaniasis in India.
- Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group.
- Biopharmaceutics: Comparison of the Efficacy of Free and Non‐ionic‐surfactant Vesicular Formulations of Paromomycin in a Murine Model of Visceral Leishmaniasis
- An analysis of T cell responsiveness in Indian kala-azar.
- Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar.
- Inflammation: Basic Principles and Clinical Correlates
- Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison.
- The importance of TGF-beta in murine visceral leishmaniasis.
- Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis.
- Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex.
Cited by
- Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.
- Cloning of S-Adenosyl-l-Methionine:C-24-Δ-Sterol-Methyltransferase (ERG6) from Leishmania donovani and Characterization of mRNAs in Wild-Type and Amphotericin B-Resistant Promastigotes
- Interleukin 10 receptor blockade--pentavalent antimony treatment in experimental visceral leishmaniasis.
- Molecular cloning and biochemical characterization of Leishmania donovani serine hydroxymethyltransferase.
- Microscopy and polymerase chain reaction detection of Leishmania chagasi in the pleural and ascitic fluid of a patient with AIDS: Case report and review of diagnosis and therapy of visceral leishmaniasis.
- [Childhood Mediterranean visceral leishmaniasis].
- Immune Regulation during Chronic Visceral Leishmaniasis
- Differential gene expression studies to explore the molecular mechanism of drug resistance in Leishmania donovani field isolates
- 16α‐Hydroxycleroda‐3,13 (14)Z‐dien‐15,16‐olide from Polyalthia longifolia: a safe and orally active antileishmanial agent
- Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ‐dependent induction and expansion of regulatory T cells in mice
- Cloning, overexpression and characterization of Leishmania donovani squalene synthase.
- Detección in silico de segundos usos de medicamentos con potencial acción leishmanicida
- Vaccines in leishmaniasis: advances in the last five years
- In vitro cytotoxic, antileishmanial and antifungal activities of ethnopharmacologically selected Gabonese plants.
- A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India
- Orphan drug approvals of 2014: Europe and the United States
- Peganine hydrochloride dihydrate an orally active antileishmanial agent.
- The metabolism of S-nitrosothiols in the trypanosomatids: the role of ovothiol A and trypanothione.
- [Visceral childhood leishmaniasis: diagnosis and treatment].
- Phospholipases A in Trypanosomatids
Related papers
- Leishmania donovani Develops Resistance to Drug Combinations
- Visceral leishmaniasis (kala-azar): challenges ahead.
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
- Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
- Leishmaniasis
- A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy
- Current treatment of visceral leishmaniasis (Kala-azar): an overview
- The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression.
- Combination of paromomycin and miltefosine promotes TLR4-dependent induction of antileishmanial immune response in vitro.